NOTICE: This Consumer Medicine Information (CMI) is intended for persons
Read moreMadeline
Home »
Bristol Myers Squibb Announces Deucravacitinib (BMS-986165) Demonstrated Superiority to Placebo and Otezla® (apremilast) in Pivotal Phase 3 Psoriasis Study
PRINCETON, N.J.–(BUSINESS WIRE) November 3, 2020 — Bristol Myers Squibb
Read morePlacebo effect could treat pain
Placebo pain relief is reproducible in patients with chronic pain
Read moreAlbiglutide Beats Placebo for Cardiovascular Events in T2DM
THURSDAY, Oct. 4, 2018 — For patients with type 2
Read moreReview of Vitamin D research identifies ethical issues in placebo use
Since World War II, medical ethics in research studies involving
Read more